Hutchmed China Limited's ability to collect accounts receivable sequentially worsen to 3.6, indicating more challenging environment then in the third quarter 2025, but still, it is a far cry from any concerns. Hutchmed China Limited's Accounts Receivable average collection period in the Dec 31 2025 quarter, has increased to 101 days, from 92 days, in the 0 quarter.

If we take a look into Healthcare sector 421 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2879, from overall ranking in the third quarter 2025 at 3127.

What is Receivable Turnover Ratio?
What is Hutchmed China Limited Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HCM Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	-16.07 %	-16.07 %	611.89 %	-16.07 %	470.8 %
Y / Y Revenue Change	-12.96 %	-	-	-	-24.8 %
Receivable Turnover Ratio (TTM)	3.6	3.97	3.81	5.13	4.87
HCM's Total Ranking	# 2879	# 3127	#	#	#
Accounts Receivable average collection period days	101	92	96	71	75
Seq. Receivable Change	0 %	-30.59 %	44.08 %	-16.07 %	0 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 135
Healthcare Sector	# 422
Overall Market	# 2879

Receivable Turnover Ratio Statistics
High	Average	Low
1.08	0.49	0.26
0		(Dec 31 2021)

HCM Company Profile • Back to HCM Efficiency Comparisons • Compare HCM Receivables Turnover Ratio to its Competitors

Financial Statements
Hutchmed China Limited's Accounts Receivable	$ 137 Millions	Visit HCM's Balance sheet
Hutchmed China Limited's Sales TTM	$ 549 Millions	Visit HCM's Income Statement
Sources of HCM's Revenues		Visit HCM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
HCM's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
HCM's Growth Rates	HCM's Roa	HCM's Inventory Turnover Ratio	HCM's Dividend Comparisons
HCM's Profitability Ratios	HCM's Roi	HCM's Asset Turnover Ratio	HCM's Dividend Growth
HCM's Valuation Ratios	HCM's Roe	HCM's Financial Strength Ratios	HCM's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Uniqure N v	10.98	$ 16.098 Millions	$ 1.466 Millions
National Healthcare Corp	10.92	$ 1,517.781 Millions	$ 138.939 Millions
Novavax inc	10.92	$ 1,123.479 Millions	$ 102.881 Millions
Vivos Therapeutics Inc	10.91	$ 16.542 Millions	$ 1.517 Millions
Cue Biopharma Inc	10.70	$ 27.466 Millions	$ 2.566 Millions
Inventiva S a	10.68	$ 13.898 Millions	$ 1.301 Millions
Lifeloc Technologies Inc	10.58	$ 9.027 Millions	$ 0.853 Millions
Exact Sciences Corporation	10.49	$ 3,245.310 Millions	$ 309.460 Millions
Bioaffinity Technologies Inc	10.37	$ 6.162 Millions	$ 0.594 Millions
Mdxhealth Sa	10.36	$ 107.875 Millions	$ 10.410 Millions
Zomedica Corp	10.34	$ 32.583 Millions	$ 3.150 Millions
Bioxcel Therapeutics Inc	10.27	$ 0.642 Millions	$ 0.063 Millions
Utah Medical Products Inc	10.25	$ 38.001 Millions	$ 3.706 Millions
Addus Homecare Corp	10.15	$ 1,421.874 Millions	$ 140.113 Millions
Biolife Solutions Inc	10.11	$ 96.118 Millions	$ 9.506 Millions
Aquestive Therapeutics Inc	10.03	$ 44.545 Millions	$ 4.441 Millions
Viemed Healthcare Inc	9.97	$ 270.280 Millions	$ 27.120 Millions
Veracyte Inc	9.94	$ 489.532 Millions	$ 49.270 Millions
Sanuwave Health Inc	9.92	$ 44.051 Millions	$ 4.439 Millions
Sunshine Biopharma Inc	9.91	$ 36.306 Millions	$ 3.662 Millions
Vireo Growth Inc.	9.89	$ 268.769 Millions	$ 27.182 Millions
Madrigal Pharmaceuticals Inc	9.87	$ 958.403 Millions	$ 97.105 Millions
International Stem Cell Corporation	9.86	$ 9.100 Millions	$ 0.923 Millions
Kestra Medical Technologies Ltd	9.85	$ 79.728 Millions	$ 8.092 Millions
Encompass Health Corporation	9.63	$ 5,935.200 Millions	$ 616.475 Millions
Biodesix Inc	9.62	$ 88.499 Millions	$ 9.200 Millions
Tandem Diabetes Care Inc	9.54	$ 1,011.039 Millions	$ 106.022 Millions
Argenx Se	9.51	$ 8,399.366 Millions	$ 883.537 Millions
Prenetics Global Limited	9.51	$ 91.790 Millions	$ 9.656 Millions
Irhythm Holdings Inc	9.49	$ 746.250 Millions	$ 78.664 Millions

Date modified: 2026-07-07T11:20:53+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.